Announcement on Holding the 1st Investor Reception Day 2026
Filed with SSE · · 5 pages · Chinese
Summary by 6ix AI
The event is scheduled to take place at the company's base and headquarters, providing an opportunity for investors to engage with key company personnel. Participants are required to register in advance and sign a commitment letter regarding the confidentiality of information during the visit. The announcement includes details about the schedule, location, and arrangements for transportation for attendees.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Shouxiangu Pharmaceutical Holding Co. Ltd. on 6ix
Earlier from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Resignation of Senior Management Member
- Announcement on Convening Performance and Cash Dividend Meeting for 2025 and Q1 2026
- Notice on Convening the 2025 Annual General Meeting
- Announcement on Postponement of Disclosure of 2025 Annual Report
- Announcement on Not Revising Downward the Conversion Price of "Shouxiangu 22 Convertible Bonds"
Later from Zhejiang Shouxiangu Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Follow-up Rating Results of "Shouxiangu 22 Convertible Bonds" in 2026
- Announcement on Conversion Result of "Shouxiangu 22 Convertible Bond" and Share Changes
- Announcement on Change of Securities Affairs Representative
- Announcement on Resolutions of the 10th Meeting of the 5th Board of Directors
Follow Zhejiang Shouxiangu Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Shouxiangu Pharmaceutical